BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 2642771)

  • 1. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen.
    Jun HS; Yoon JW
    Adv Exp Med Biol; 1994; 347():207-20. PubMed ID: 7976732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
    Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
    Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
    O'Kell AL; Wasserfall C; Catchpole B; Davison LJ; Hess RS; Kushner JA; Atkinson MA
    Diabetes; 2017 Jun; 66(6):1443-1452. PubMed ID: 28533295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta-cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats.
    Ko IY; Ihm SH; Yoon JW
    Diabetologia; 1991 Aug; 34(8):548-54. PubMed ID: 1936657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in the sera from newly diagnosed diabetic nod mice: evidence against cross-reactivity with a putative beta-cell surface autoantigen.
    Formby B; Miller N
    Diabetes Res; 1990 Jan; 13(1):13-7. PubMed ID: 2097091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
    Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM.
    Christensen UB; Sparre T; Cooke A; Andersen HU; Mandrup-Poulsen T; Nerup J
    Autoimmunity; 1998; 28(2):91-107. PubMed ID: 9771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.
    Ziegler AI; Le Page MA; Maxwell MJ; Stolp J; Guo H; Jayasimhan A; Hibbs ML; Santamaria P; Miller JF; Plebanski M; Silveira PA; Slattery RM
    Diabetologia; 2013 Dec; 56(12):2659-68. PubMed ID: 24013782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and genetic studies of diabetes in the BB rat.
    Parfrey NA; Prud'homme GJ; Colle E; Fuks A; Seemayer TA; Guttmann RD; Ono SJ
    Crit Rev Immunol; 1989; 9(1):45-65. PubMed ID: 2651002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects.
    Faustman D; Schoenfeld D; Ziegler R
    Diabetes; 1991 May; 40(5):590-7. PubMed ID: 1827080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic analysis of beta-cell autoimmunity in NOD mice. Relationship of insulitis to T-lymphocyte-receptor beta nod and A beta nod genes.
    Winter WE; Shimpo K; Obata M; Yamada K; Luchetta R
    Diabetes; 1990 Aug; 39(8):975-82. PubMed ID: 1973674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of autoimmune diabetes mellitus.
    Rossini AA; Mordes JP; Greiner DL
    Curr Opin Immunol; 1989-1990 Apr; 2(4):598-603. PubMed ID: 2700903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.